| Overview |
| bsm-52929R |
| CaMKII alpha (3C5) Monoclonal Antibody |
| WB, FCM |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| N terminus human CaMKII alpha |
| Monoclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C for 12 months. |
| Target |
| 815 |
| Q9UQM7 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha, CaM kinase II subunit alpha, CaMK-II subunit alpha |
| CaM-kinase II (CAMK2) is a prominent kinase in the central nervous system that may function in long-term potentiation and neurotransmitter release. Member of the NMDAR signaling complex in excitatory synapses it may regulate NMDAR-dependent potentiation of the AMPAR and synaptic plasticity (By similarity). |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |